Home/Pelthos Therapeutics/Peter Greenleaf, MBA
PG

Peter Greenleaf, MBA

Chairman of the Board

Pelthos Therapeutics

Pelthos Therapeutics Pipeline

DrugIndicationPhase
ZELSUVMI™ (berdazimer topical gel, 10.3%)Molluscum ContagiosumApproved
Xepi® (ozenoxacin) Cream, 1%ImpetigoApproved
Xeglyze® (abametapir) Lotion, 0.74%Head LiceApproved